JD Mowery, new KBI Biopharma and Selexis SA CEO
April 20, 2023 11:38 AM EDTUpdated April 21, 09:16 AM
People
Pharma
Manufacturing

KBI Bio­phar­ma and Se­lex­is hire J.D. Mow­ery as new CEO

Tyler Patchen

News Reporter

KBI Bio­phar­ma is the lat­est con­tract man­u­fac­tur­er mak­ing change at the top in an on­go­ing C-suite shuf­fle oc­cur­ring across the CD­MO space over the past …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times